author-photo

Marco Basiricò

University of Turin

19

Papers

148

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy

2021 Vaccine
Show All
- Source
- Cite
- Save
Citations (0)
A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (18)
Preclinical study of trabectedin (TR) and poly(ADP-ribose)polymerase 1 (PARP-1) inhibitor combination in soft tissue sarcoma (STS).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3709: PARP1 expression (PARP1expr) drives synergy between PARP1 inhibitors (PARP1-Is) and trabectedin (TR)

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Predictive biomarkers of trabectedin (TR) and olaparib (OL) synergism in preclinical models of bone and soft tissue sarcoma (BSTS).

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-213: The antitumor effect of trabectedin (TR) is potentiated by olaparib (OL) in preclinical models of bone and soft tissue sarcomas (STS).

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
350 Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitors Potentiate Trabectedin Activity in Preclinical Models of Bone and Soft Tissue Sarcomas

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)